A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease - PubMed (original) (raw)
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease
K Hensley et al. Proc Natl Acad Sci U S A. 1994.
Abstract
beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.
Similar articles
- A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
Butterfield DA, Martin L, Carney JM, Hensley K. Butterfield DA, et al. Life Sci. 1996;58(3):217-28. doi: 10.1016/0024-3205(95)02279-1. Life Sci. 1996. PMID: 9499162 - Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
Yatin SM, Yatin M, Varadarajan S, Ain KB, Butterfield DA. Yatin SM, et al. J Neurosci Res. 2001 Mar 1;63(5):395-401. doi: 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q. J Neurosci Res. 2001. PMID: 11223914 - The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Hara H, Ohashi R, Takegoshi K, Fukuda H, Nagao M, Shimizu T, Shirasawa T. Irie K, et al. Mini Rev Med Chem. 2007 Oct;7(10):1001-8. doi: 10.2174/138955707782110187. Mini Rev Med Chem. 2007. PMID: 17979802 Review. - Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
Aleksis R, Oleskovs F, Jaudzems K, Pahnke J, Biverstål H. Aleksis R, et al. Biochimie. 2017 Sep;140:176-192. doi: 10.1016/j.biochi.2017.07.011. Epub 2017 Jul 25. Biochimie. 2017. PMID: 28751216 Review.
Cited by
- Centella asiatica Attenuates Amyloid-β-Induced Oxidative Stress and Mitochondrial Dysfunction.
Gray NE, Sampath H, Zweig JA, Quinn JF, Soumyanath A. Gray NE, et al. J Alzheimers Dis. 2015;45(3):933-46. doi: 10.3233/JAD-142217. J Alzheimers Dis. 2015. PMID: 25633675 Free PMC article. - Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo.
Asuni AA, Guridi M, Sanchez S, Sadowski MJ. Asuni AA, et al. Neurochem Int. 2015 Nov;90:152-65. doi: 10.1016/j.neuint.2015.08.006. Epub 2015 Aug 8. Neurochem Int. 2015. PMID: 26265052 Free PMC article. - Brain neurons express ornithine decarboxylase-activating antizyme inhibitor 2 with accumulation in Alzheimer's disease.
Mäkitie LT, Kanerva K, Polvikoski T, Paetau A, Andersson LC. Mäkitie LT, et al. Brain Pathol. 2010 May;20(3):571-80. doi: 10.1111/j.1750-3639.2009.00334.x. Epub 2009 Sep 22. Brain Pathol. 2010. PMID: 19832840 Free PMC article. - Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease.
Wagner SL, Munoz B. Wagner SL, et al. J Clin Invest. 1999 Nov;104(10):1329-32. doi: 10.1172/JCI8729. J Clin Invest. 1999. PMID: 10562291 Free PMC article. Review. No abstract available. - Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by Citrate.
Park YH, Kim YJ, Son IH, Yang HD. Park YH, et al. Korean J Physiol Pharmacol. 2009 Aug;13(4):273-9. doi: 10.4196/kjpp.2009.13.4.273. Epub 2009 Aug 31. Korean J Physiol Pharmacol. 2009. PMID: 19885010 Free PMC article.
References
- Trends Neurosci. 1993 Oct;16(10):409-14 - PubMed
- Brain Res. 1993 Sep 3;621(1):35-49 - PubMed
- J Neurol Sci. 1980 Mar;45(2-3):323-30 - PubMed
- J Biol Chem. 1983 Oct 10;258(19):11823-7 - PubMed
- J Free Radic Biol Med. 1986;2(1):13-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical